MSCLF
Satellos Bioscience Inc
Price Chart
No historical data available
Latest Quote
$12.14
+0.59 (+5.11%)
Current Price
| Previous Close | $11.55 |
| Open | $0.88 |
| Day High | $0.94 |
| Day Low | $0.88 |
| Volume | 33,600 |
Stock Information
| Shares Outstanding | 15.46M |
| Cash Equivalents | $34.61M |
| Net Income | $-21.57M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $187.67M |
| P/E Ratio | 4.72 |
| EPS (TTM) | $2.57 |
| Exchange | PNK |
Recent Price History
No history data available. Data will be fetched automatically.
About Satellos Bioscience Inc
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
đ° Latest News
Satellos Bioscience Receives Clearance by FDA, Global Regulators, For Phase 2 Study of SAT-3247
MT Newswires âĸ 2025-12-09T12:51:39ZSatellos Bioscience: Q3 Earnings Snapshot
Associated Press Finance âĸ 2025-11-14T13:29:23ZSatellos Files IND to Start Phase 2 U.S. Trial of SAT-3247 for Duchenne Muscular Dystrophy
MT Newswires âĸ 2025-09-22T11:40:13ZHere's Why We're Watching Satellos Bioscience's (TSE:MSCL) Cash Burn Situation
Simply Wall St. âĸ 2025-09-05T14:53:12Z
Satellos Bioscience: Q2 Earnings Snapshot
Associated Press Finance âĸ 2025-08-13T11:59:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Reconciled Cost Of Revenue | - | - | - | $94,053 |
| Cost Of Revenue | - | - | - | $94,053 |
| Expenses | ||||
| Interest Expense | $0 | $133,424 | $0 | $772,797 |
| Total Expenses | $19,375,832 | $11,656,113 | $6,209,844 | $3,687,277 |
| Other Income Expense | $-1,158,035 | $-1,192,522 | $-2,175,066 | $-7,707,294 |
| Net Non Operating Interest Income Expense | $955,274 | $871,401 | $46,419 | $-766,534 |
| Interest Expense Non Operating | $0 | $133,424 | $0 | $772,797 |
| Operating Expense | $19,375,832 | $11,656,113 | $6,209,844 | $3,687,277 |
| Other Operating Expenses | $540,695 | $437,208 | $292,514 | $852,716 |
| General And Administrative Expense | $5,162,383 | $4,567,315 | $2,917,772 | $1,133,178 |
| Other Non Operating Income Expenses | - | - | $-35,862 | $-34,385 |
| Total Other Finance Cost | - | - | - | $934,197 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Net Interest Income | $955,274 | $871,401 | $46,419 | $-766,534 |
| Interest Income | $955,274 | $1,004,824 | $46,419 | $6,263 |
| Normalized Income | $-18,420,558 | $-10,784,713 | $-6,737,194 | $-4,488,195 |
| Net Income From Continuing And Discontinued Operation | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Total Operating Income As Reported | $-19,375,832 | $-11,656,113 | $-6,209,844 | - |
| Net Income Common Stockholders | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Net Income | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Net Income Including Noncontrolling Interests | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Net Income Continuous Operations | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Pretax Income | $-19,578,592 | $-11,977,235 | $-8,338,491 | $-12,161,105 |
| Special Income Charges | $-2,759,913 | $-321,122 | $-2,125,700 | $-7,677,528 |
| Interest Income Non Operating | $955,274 | $1,004,824 | $46,419 | $6,263 |
| Operating Income | $-19,375,832 | $-11,656,113 | $-6,209,844 | $-3,687,277 |
| Depreciation Amortization Depletion Income Statement | $13,935 | $5,277 | $248,305 | $129,947 |
| Depreciation And Amortization In Income Statement | $13,935 | $5,277 | $248,305 | $129,947 |
| Depreciation Income Statement | $13,935 | $5,277 | $2,947 | $580 |
| Amortization Of Intangibles Income Statement | - | $0 | $245,358 | $129,367 |
| Gross Profit | - | - | - | $-94,053 |
| Per Share | ||||
| Diluted EPS | $0.17 | $-0.14 | $-0.24 | $-0.50 |
| Basic EPS | $0.17 | $-0.14 | $-0.24 | $-0.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-570,085 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-18,406,622 | $-10,646,012 | $-5,915,119 | $-3,585,451 |
| Total Unusual Items | $-1,158,035 | $-1,192,522 | $-2,175,066 | $-7,672,909 |
| Total Unusual Items Excluding Goodwill | $-1,158,035 | $-1,192,522 | $-2,175,066 | $-7,672,909 |
| Reconciled Depreciation | $13,935 | $5,277 | $248,305 | $129,947 |
| EBITDA (Bullshit earnings) | $-19,564,657 | $-11,838,535 | $-8,090,186 | $-11,258,361 |
| EBIT | $-19,578,592 | $-11,843,811 | $-8,338,491 | $-11,388,308 |
| Diluted Average Shares | $114,778,351 | $86,404,762 | $35,680,113 | $24,076,457 |
| Basic Average Shares | $114,778,351 | $86,404,762 | $35,680,113 | $24,076,457 |
| Diluted NI Availto Com Stockholders | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Tax Provision | $0 | $0 | $3,684 | $0 |
| Impairment Of Capital Assets | $2,759,913 | $0 | $2,125,700 | $0 |
| Gain On Sale Of Security | $1,601,878 | $-871,401 | $-49,366 | $4,619 |
| Research And Development | $13,658,819 | $6,646,314 | $2,751,253 | $1,571,437 |
| Selling General And Administration | $5,162,383 | $4,567,315 | $2,917,772 | $1,133,178 |
| Other Gand A | $1,615,117 | $1,837,781 | $1,173,003 | $353,020 |
| Salaries And Wages | $3,547,266 | $2,729,534 | $1,744,769 | $761,974 |
| Other Special Charges | - | $321,122 | - | - |
| Amortization | - | $0 | $245,358 | $129,367 |
| Restructuring And Mergern Acquisition | - | - | $0 | $7,677,528 |
| Insurance And Claims | - | - | $25,268 | $18,183 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $47,284,332 | $27,708,428 | $-403,036 | $2,625,101 |
| Total Assets | $50,876,191 | $33,392,130 | $4,567,492 | $9,871,313 |
| Total Non Current Assets | $3,484 | $2,997,136 | $2,922,930 | $5,602,459 |
| Goodwill And Other Intangible Assets | $0 | $2,951,907 | $2,885,352 | $5,596,034 |
| Current Assets | $50,872,707 | $30,394,995 | $1,645,299 | $4,268,855 |
| Hedging Assets Current | $0 | $3,015 | $2,210 | $0 |
| Prepaid Assets | $1,764,226 | $111,563 | $33,893 | $34,218 |
| Receivables | $436,179 | $439,469 | $191,571 | $414,099 |
| Taxes Receivable | $436,179 | $439,469 | $191,571 | $412,700 |
| Cash Cash Equivalents And Short Term Investments | $48,672,301 | $29,840,947 | $1,417,625 | $3,820,539 |
| Cash And Cash Equivalents | $40,175,168 | $16,634,253 | $1,417,625 | $3,820,539 |
| Cash Equivalents | $15,728,231 | $16,175,185 | $818,597 | $2,363,553 |
| Cash Financial | $24,446,937 | $459,068 | $599,027 | $1,456,986 |
| Other Intangible Assets | - | - | $3,916,190 | $5,596,034 |
| Accounts Receivable | - | - | $0 | $1,398 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,591,859 | $2,731,796 | $2,085,175 | $1,650,179 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $3,591,859 | $2,731,796 | $2,085,175 | $1,650,179 |
| Payables And Accrued Expenses | $3,591,859 | $2,731,796 | $2,085,175 | $1,650,179 |
| Payables | $2,068,019 | $783,959 | $1,080,165 | $885,337 |
| Accounts Payable | $2,068,019 | $783,959 | $1,080,165 | $885,337 |
| Equity | ||||
| Common Stock Equity | $47,284,332 | $30,660,335 | $2,482,317 | $8,221,135 |
| Total Equity Gross Minority Interest | $47,284,332 | $30,660,335 | $2,482,317 | $8,221,135 |
| Stockholders Equity | $47,284,332 | $30,660,335 | $2,482,317 | $8,221,135 |
| Other Equity Interest | $19,246,232 | $13,396,653 | $804,598 | $959,468 |
| Gains Losses Not Affecting Retained Earnings | $-151,199 | $-11,307 | $-5,158 | $-1,133 |
| Other Equity Adjustments | $-151,199 | $-11,307 | $-5,158 | $-1,133 |
| Retained Earnings | $-52,676,649 | $-35,807,327 | $-23,292,809 | $-15,914,466 |
| Other | ||||
| Ordinary Shares Number | $165,819,872 | $112,791,658 | $41,797,613 | $32,997,613 |
| Share Issued | $165,819,872 | $112,791,658 | $41,797,613 | $32,997,613 |
| Tangible Book Value | $47,284,332 | $27,708,428 | $-403,036 | $2,625,101 |
| Invested Capital | $47,284,332 | $30,660,335 | $2,482,317 | $8,221,135 |
| Working Capital | $47,280,848 | $27,663,199 | $-439,876 | $2,618,676 |
| Total Capitalization | $47,284,332 | $30,660,335 | $2,482,317 | $8,221,135 |
| Additional Paid In Capital | $7,196,957 | $6,409,619 | $2,717,359 | $969,028 |
| Capital Stock | $73,668,992 | $46,672,697 | $22,258,326 | $22,208,237 |
| Common Stock | $73,668,992 | $46,672,697 | $22,258,326 | $22,208,237 |
| Current Accrued Expenses | $1,523,840 | $1,947,837 | $1,005,010 | $764,842 |
| Investments And Advances | $0 | $30,906 | $30,946 | $0 |
| Net PPE | $3,484 | $14,322 | $6,631 | $6,425 |
| Gross PPE | $3,484 | $14,322 | $10,315 | $7,912 |
| Other Properties | $3,484 | $14,322 | - | $8,192 |
| Other Short Term Investments | $8,497,133 | $13,206,694 | - | - |
| Accumulated Depreciation | - | $-13,000 | $-3,684 | $-1,487 |
| Machinery Furniture Equipment | - | $32,000 | $10,315 | $7,912 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,406,058 | $-8,746,419 | $-4,263,189 | $-3,953,630 |
| Operating Activities | ||||
| Operating Cash Flow | $-17,401,877 | $-8,732,851 | $-4,260,978 | $-3,947,947 |
| Cash Flow From Continuing Operating Activities | $-17,401,877 | $-8,732,851 | $-4,157,825 | $-3,947,947 |
| Operating Gains Losses | $-1,015,197 | $1,192,522 | $18,420 | $-15,509 |
| Investing Activities | ||||
| Capital Expenditure | $-4,181 | $-13,569 | $-2,210 | $-5,683 |
| Investing Cash Flow | $4,416,140 | $-13,220,262 | $-2,210 | $1,363,254 |
| Cash Flow From Continuing Investing Activities | $4,416,140 | $-13,220,262 | $-2,210 | $1,363,254 |
| Net Other Investing Changes | - | - | - | $1,368,937 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $29,823,229 | $24,470,828 | $2,044,651 | $5,551,816 |
| Financing Cash Flow | $37,266,843 | $38,013,719 | $2,044,651 | $5,843,604 |
| Cash Flow From Continuing Financing Activities | $37,266,843 | $38,147,143 | $2,044,651 | $5,843,604 |
| Net Common Stock Issuance | $29,823,229 | $24,470,828 | $2,044,651 | $5,551,816 |
| Common Stock Issuance | $29,823,229 | $24,470,828 | $2,044,651 | $5,551,816 |
| Net Other Financing Charges | - | $454,545 | - | - |
| Cash Dividends Paid | - | $0 | $0 | - |
| Other | ||||
| Repayment Of Debt | $0 | $-1,976,481 | $0 | - |
| Issuance Of Debt | $0 | $1,691,542 | $0 | $146,329 |
| End Cash Position | $40,175,168 | $16,634,253 | $1,417,625 | $3,820,539 |
| Beginning Cash Position | $15,375,665 | $1,450,324 | $3,589,007 | $562,760 |
| Effect Of Exchange Rate Changes | $518,398 | $-876,677 | $-55,998 | $-1,133 |
| Changes In Cash | $24,281,106 | $16,060,606 | $-2,115,385 | $3,258,911 |
| Proceeds From Stock Option Exercised | $7,443,614 | $13,827,831 | $0 | $145,459 |
| Net Issuance Payments Of Debt | $0 | $-284,939 | $0 | $146,329 |
| Net Long Term Debt Issuance | $0 | $-284,939 | $0 | $146,329 |
| Long Term Debt Payments | $0 | $-1,976,481 | $0 | - |
| Long Term Debt Issuance | $0 | $1,691,542 | $0 | $146,329 |
| Net Investment Purchase And Sale | $4,420,321 | $-13,206,694 | $0 | - |
| Sale Of Investment | $30,434,995 | $0 | - | - |
| Purchase Of Investment | $-26,014,674 | $-13,206,694 | $0 | - |
| Net PPE Purchase And Sale | $-4,181 | $-13,569 | $-2,210 | $-5,683 |
| Purchase Of PPE | $-4,181 | $-13,569 | $-2,210 | $-5,683 |
| Change In Working Capital | $-714,191 | $278,155 | $730,180 | $-380,887 |
| Change In Payables And Accrued Expense | $960,152 | $598,523 | $534,925 | $-306,246 |
| Change In Prepaid Assets | $-1,644,382 | $-76,888 | $-1,474 | $-21,780 |
| Change In Receivables | $-29,961 | $-243,480 | $196,729 | $-52,861 |
| Other Non Cash Items | $-340,025 | $133,424 | $-103,154 | $7,717,633 |
| Stock Based Compensation | $1,472,279 | $1,635,007 | $1,061,008 | $761,974 |
| Asset Impairment Charge | $2,759,913 | $0 | $2,126,437 | $0 |
| Depreciation Amortization Depletion | $13,935 | $5,277 | $248,305 | $129,947 |
| Depreciation And Amortization | $13,935 | $5,277 | $248,305 | $129,947 |
| Depreciation | $13,935 | $5,277 | $2,947 | $580 |
| Gain Loss On Investment Securities | $1,394 | $-754 | $-33,156 | $369 |
| Net Foreign Currency Exchange Gain Loss | $-1,016,590 | $872,154 | $51,577 | $-15,878 |
| Net Income From Continuing Operations | $-19,578,592 | $-11,977,235 | $-8,342,175 | $-12,161,105 |
| Interest Paid Cff | - | $-70,104 | $0 | - |
| Amortization Cash Flow | - | $0 | $245,358 | $129,367 |
| Amortization Of Intangibles | - | $0 | $245,358 | $129,367 |
| Net Business Purchase And Sale | - | - | $0 | $1,368,937 |
| Sale Of Business | - | - | $0 | $1,368,937 |
| Changes In Account Receivables | - | - | $1,314 | $31,471 |
Fetched: 2026-02-02